[HTML][HTML] Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis
The survival rate of colorectal cancer patients is adversely affected by the selection of tumors
resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is …
resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is …
[PDF][PDF] Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis
S Ghosh, R Singh, ZM Vanwinkle, H Guo, PK Vemula… - researchgate.net
The survival rate of colorectal cancer patients is adversely affected by the selection of tumors
resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is …
resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is …
Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
S Ghosh, R Singh, ZM Vanwinkle, H Guo, PK Vemula… - Theranostics, 2022 - europepmc.org
The survival rate of colorectal cancer patients is adversely affected by the selection of tumors
resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is …
resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is …
Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis
S Ghosh, R Singh, ZM Vanwinkle, H Guo… - …, 2022 - pubmed.ncbi.nlm.nih.gov
The survival rate of colorectal cancer patients is adversely affected by the selection of tumors
resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is …
resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is …